Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
05/2003
05/15/2003WO2003040107A1 Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity
05/15/2003WO2003040106A1 Preparation and use of substituted imidazoles
05/15/2003WO2003040099A1 Preparation of benzosuberonylpiperidine compounds
05/15/2003WO2003040098A1 Novel metalloproteinase inhibitors
05/15/2003WO2003040096A2 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003WO2003040086A1 5-amidino-2-hydroxybenzenesulfonamide derivatives, medicinal compositions containing the same, medicinal use thereof and intermediates in the production thereof
05/15/2003WO2003040084A1 Unsaturated 1-amino-alkylcyclohexane nmda, 5ht3 and neuronal nicotinic receptor antagonists
05/15/2003WO2003040080A2 Lipoxin a4 analogs
05/15/2003WO2003039598A1 Selective norepinephrine serotonin reuptake inhibitors for treating fibromyalgia syndrome, chronic fatique syndrome and pain
05/15/2003WO2003039575A2 Use of reelin, gas6, and protein s in the treatment of neural disorders
05/15/2003WO2003039570A1 Composition containing an extract of pericarpium zanthoxyli for protecting brain cells and improving memory
05/15/2003WO2003039565A1 Use of milk serum containing substances with benzodiazepine-like activity as adjuvants to therapy of anxiety and insomnia
05/15/2003WO2003039564A1 Selective targeting of apoptotic cells
05/15/2003WO2003039563A1 Treatment and prevention of paresthesia comprising co-therapy with anticonvulsant derivatives and potassium
05/15/2003WO2003039561A1 Pharmaceutical composition
05/15/2003WO2003039555A2 Agents for treating lesions of the nervous system
05/15/2003WO2003039554A1 Enantiomers of steroids for the enhancement of memory and cognitive function
05/15/2003WO2003039553A1 Compositions for treatment of postmenopausal female sexual dysfunction
05/15/2003WO2003039548A1 Hydrazono-malonitriles
05/15/2003WO2003039544A1 Naphtyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors
05/15/2003WO2003039543A1 Derivatives of phenoxy-n-'4-(isothiazolidin-1,1-dioxid-2yl)pheny!-valerian- acid amide and other compounds as inhibitors of the coagulation factor xa in the treatment of thromboembolic diseases and tumors
05/15/2003WO2003039540A2 D-amino acid oxidase inhibitors for learning and memory
05/15/2003WO2003039532A1 Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
05/15/2003WO2003039524A1 Anti-muscarinic agent and estrogen-agonist for treating unstable or overactive bladder
05/15/2003WO2003039523A2 OLIGONUCLEOTIDES MODIFIED WITH NOVEL α-L-RNA ANALOGUES
05/15/2003WO2003039520A1 Orodispersible tablet having high homogeneity and the preparation method thereof
05/15/2003WO2003039518A1 Oral controlled release forms useful for reducing or preventing nicotine cravings
05/15/2003WO2003039480A2 Method of treating disorder related to high cholesterol concentration
05/15/2003WO2003039472A2 Intraorally disintegrating valdecoxib compositions prepared by fluid bed granulation process
05/15/2003WO2003039469A2 Heteroaryl derivatives as superior ligands for nociceptin receptor orl-1
05/15/2003WO2003039454A2 Beta-secretase inhibitors and methods of use
05/15/2003WO2003039452A2 Nutritional supplements and methods for prevention, reduction and treatment of radiation injury
05/15/2003WO2003039451A2 Thiazole pyridazinones as adenosine antagonists
05/15/2003WO2003039449A2 Modulation of dopaminergic neurons
05/15/2003WO2003039446A2 Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible no-synthase
05/15/2003WO2003039342A2 Methods and compositions to treat pain and painful disorders using 577, 20739 or 57145
05/15/2003WO2003039231A2 Compounds and methods for treating transplant rejection
05/15/2003WO2003039225A2 Antigen arrays comprising rankl for treatment of bone disease
05/15/2003WO2003031435A8 Pyrazole derivatives as glycine transporter inhibitors
05/15/2003WO2002100836A3 Compounds, compositions and methods for modulating beta-amyloid production
05/15/2003WO2002097032A3 Proteins associated with cell growth, differentiation, and death
05/15/2003WO2002094856A3 Gpe analogs and peptidomimetics
05/15/2003WO2002092115A3 Method of preventing cell death using segments of neural thread proteins
05/15/2003WO2002083926A3 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions
05/15/2003WO2002083179A3 Fusion proteins
05/15/2003WO2002069976A3 Use of ovarian hormone for increasing neural stem cell number
05/15/2003WO2002067961A3 Therapeutic uses of herbal compositions
05/15/2003WO2002064795A3 Putative human enzymes
05/15/2003WO2002058730A3 Compositions for treatment of ocular neovascularization
05/15/2003WO2002058679A3 Antiangiogenic compounds and an assay for inhibitors of cell invasion
05/15/2003WO2002057298A3 C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases
05/15/2003WO2002056027A3 Regulation of neutral development by daedalos
05/15/2003WO2002055108A9 Targeted modification of intracellular compounds
05/15/2003WO2002044737A3 Diagnostic and therapeutic compositions and methods related to anaphylatoxin c3a receptor
05/15/2003WO2002041842A3 Antibody pti-hs7 for treatment of alzheimer's disease and other amyloidoses and parkinson's disease
05/15/2003WO2002041002A3 Discordant helix stabilization for prevention of amyloid formation
05/15/2003WO2002040480A3 Crf receptor antagonists and methods relating thereto
05/15/2003WO2002040016A8 Association of calpain inhibitors and reactive oxygen species trapping agents
05/15/2003WO2002038208A3 Device and method for the cessation of smoking
05/15/2003WO2002029059A9 Nogo receptor homologs
05/15/2003WO2002026781A9 Ige receptor antagonists
05/15/2003WO2002018407A9 Antisense oligonucleotides against vanilloid receptor 1
05/15/2003WO2002000629A9 Iminopyrimidine nmda nr2b receptor antagonists
05/15/2003WO2001079173A3 Enamine derivatives as cell adhesion molecules
05/15/2003US20030092919 Method for the preparation of citalopram
05/15/2003US20030092908 Autoimmune diseases; rheumatic diseases; multiple sclerosis; inflammatory bowel disease; immunosuppressants
05/15/2003US20030092771 Inhibitors of transcription factor NF-kappaB
05/15/2003US20030092769 Diaryl-enynes
05/15/2003US20030092764 Oxidation resistance
05/15/2003US20030092762 Anti-inflammatory nitro and thia-fatty acids
05/15/2003US20030092761 Method for the preparation of citalopram
05/15/2003US20030092759 Anticonvulsant derivatives useful for the treatment of restless limb syndrome and periodic limb movement disorder
05/15/2003US20030092748 Benzenesulfonamide derivatives and their use as MEK inhibitors
05/15/2003US20030092747 Secretase inhibitor
05/15/2003US20030092732 Eating disorders; dietetics; antiinflammatory agents; autoimmune diseases
05/15/2003US20030092727 Hydroxamic and carboxylic acid derivatives
05/15/2003US20030092721 Antiinflammatory agents; rheumatic diseases
05/15/2003US20030092719 Methods and kits for treating depression or preventing deterioration of cognitive function
05/15/2003US20030092717 Inhibitors of p38 kinase
05/15/2003US20030092716 Antihypoxic agents
05/15/2003US20030092715 Aryl and biaryl compounds having MCH modulatory activity
05/15/2003US20030092714 Heterocyclic inhibitors of ERK2 and uses thereof
05/15/2003US20030092713 Antiinflammatory agents; antiallergens; psychological disorders
05/15/2003US20030092712 Antiinflammatory agents; rheumatic diseases
05/15/2003US20030092704 Novel arylglycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds
05/15/2003US20030092703 Caspase inhibitors and uses thereof
05/15/2003US20030092702 Antiinflammatory agents; autoimmune disease; autoimmune diseases
05/15/2003US20030092692 Alzheimer's and parkinson's disease
05/15/2003US20030092678 Muscle relaxants, controlling immunology, sexual disorders, rheumatic diseases
05/15/2003US20030092677 Glutamate receptor antagonists
05/15/2003US20030092645 Cloning, expression, viral and delivery vectors and hosts
05/15/2003US20030092636 Treatment and prevention of paresthesia comprising co-therapy with anticonvulsant derivatives and potassium
05/15/2003US20030092633 Preventing desensitization of receptors
05/15/2003US20030092629 Inhibitors of memapsin 2 and use thereof
05/15/2003US20030092613 Alpha7 nicotinic receptor peptides as ligands for beta amyloid peptides
05/15/2003US20030092176 Ependymal neural stem cells and method for their isolation
05/15/2003US20030092163 Probiotic bifidobacterium strains
05/15/2003US20030092133 Interleukins-21 and 22
05/15/2003US20030092129 Nervous system polypeptide for use in the treatment of nervous system disorders
05/15/2003US20030092120 Novel human K+ ion channel and therapeutic applications thereof
1 ... 1214 1215 1216 1217 1218 1219 1220 1221 1222 1223 1224 1225 1226 1227 1228 1229 1230 1231 1232 1233 1234 ... 1833